Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Harvard Bioscience (HBIO) Short-term Investments (2018 - 2024)

Historic Short-term Investments for Harvard Bioscience (HBIO) over the last 2 years, with Q2 2024 value amounting to $34000.0.

Harvard Bioscience's Short-term Investments changed N/A to $34000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $34000.0, marking a year-over-year change of. This contributed to the annual value of -$170000.0 for FY2018, which is N/A changed from last year.
Per Harvard Bioscience's latest filing, its Short-term Investments stood at $34000.0 for Q2 2024.
In the past 5 years, Harvard Bioscience's Short-term Investments registered a high of $34000.0 during Q2 2024, and its lowest value of $34000.0 during Q2 2024.